These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 16093205)

  • 1. Characterization of the absorption of theophylline from immediate- and controlled-release dosage forms with a numerical approach using the in vitro dissolution-permeation process using caco-2 cells.
    Noureddine N; Zerrouk N; Nicolis I; Allain P; Sfar S; Chaumeil JC
    Drug Dev Ind Pharm; 2005 May; 31(4-5):397-404. PubMed ID: 16093205
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In Vitro-In Vivo Predictive Dissolution-Permeation-Absorption Dynamics of Highly Permeable Drug Extended-Release Tablets via Drug Dissolution/Absorption Simulating System and pH Alteration.
    Li ZQ; Tian S; Gu H; Wu ZG; Nyagblordzro M; Feng G; He X
    AAPS PharmSciTech; 2018 May; 19(4):1882-1893. PubMed ID: 29663288
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Permeability assessment for solid oral drug formulations based on Caco-2 monolayer in combination with a flow through dissolution cell.
    Motz SA; Schaefer UF; Balbach S; Eichinger T; Lehr CM
    Eur J Pharm Biopharm; 2007 May; 66(2):286-95. PubMed ID: 17156983
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prediction of dissolution-absorption relationships from a dissolution/Caco-2 system.
    Ginski MJ; Polli JE
    Int J Pharm; 1999 Jan; 177(1):117-25. PubMed ID: 10205608
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro solubility, dissolution and permeability studies combined with semi-mechanistic modeling to investigate the intestinal absorption of desvenlafaxine from an immediate- and extended release formulation.
    Franek F; Jarlfors A; Larsen F; Holm P; Steffansen B
    Eur J Pharm Sci; 2015 Sep; 77():303-13. PubMed ID: 26091569
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of a Physiologically Relevant Population Pharmacokinetic in Vitro-in Vivo Correlation Approach for Designing Extended-Release Oral Dosage Formulation.
    Kim TH; Shin S; Bulitta JB; Youn YS; Yoo SD; Shin BS
    Mol Pharm; 2017 Jan; 14(1):53-65. PubMed ID: 27809538
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In silico predictions of gastrointestinal drug absorption in pharmaceutical product development: application of the mechanistic absorption model GI-Sim.
    Sjögren E; Westergren J; Grant I; Hanisch G; Lindfors L; Lennernäs H; Abrahamsson B; Tannergren C
    Eur J Pharm Sci; 2013 Jul; 49(4):679-98. PubMed ID: 23727464
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dissolution of theophylline from film-coated slow release mini-tablets in various dissolution media.
    Fassihi AR; Munday DL
    J Pharm Pharmacol; 1989 Jun; 41(6):369-72. PubMed ID: 2570830
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of absorption potential of poorly water-soluble drugs by using the dissolution/permeation system.
    Kataoka M; Yano K; Hamatsu Y; Masaoka Y; Sakuma S; Yamashita S
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):1317-24. PubMed ID: 23811221
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of gastric pH on oral drug absorption: In vitro assessment using a dissolution/permeation system reflecting the gastric dissolution process.
    Kataoka M; Fukahori M; Ikemura A; Kubota A; Higashino H; Sakuma S; Yamashita S
    Eur J Pharm Biopharm; 2016 Apr; 101():103-11. PubMed ID: 26873006
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization and evaluation of a modified PVPA barrier in comparison to Caco-2 cell monolayers for combined dissolution and permeation testing.
    Gantzsch SP; Kann B; Ofer-Glaessgen M; Loos P; Berchtold H; Balbach S; Eichinger T; Lehr CM; Schaefer UF; Windbergs M
    J Control Release; 2014 Feb; 175():79-86. PubMed ID: 24361370
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determination of intraluminal theophylline concentrations after oral intake of an immediate- and a slow-release dosage form.
    Brouwers J; Ingels F; Tack J; Augustijns P
    J Pharm Pharmacol; 2005 Aug; 57(8):987-96. PubMed ID: 16102254
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prediction of dissolution-absorption relationships from a continuous dissolution/Caco-2 system.
    Ginski MJ; Taneja R; Polli JE
    AAPS PharmSci; 1999; 1(2):E3. PubMed ID: 11741200
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Eudraginated polymer blends: a potential oral controlled drug delivery system for theophylline.
    Emeje M; John-Africa L; Isimi Y; Kunle O; Ofoefule S
    Acta Pharm; 2012 Mar; 62(1):71-82. PubMed ID: 22472450
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Simultaneous Analysis of Dissolution and Permeation Profiles of Nanosized and Microsized Formulations of Indomethacin Using the In Vitro Dissolution Absorption System 2.
    Li J; Li LB; Nessah N; Huang Y; Hidalgo C; Owen A; Hidalgo IJ
    J Pharm Sci; 2019 Jul; 108(7):2334-2340. PubMed ID: 30776382
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Theophylline granule formulation prepared by the wet granulation method: comparison of in vitro dissolution profiles and estimation of in vivo plasma concentrations.
    Karasulu E; Apaydin S; Ince I; Tuglular I
    Eur J Drug Metab Pharmacokinet; 2006; 31(4):291-8. PubMed ID: 17315541
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of pH on the in vitro dissolution and in vivo absorption of controlled-release theophylline in dogs.
    Vashi VI; Meyer MC
    J Pharm Sci; 1988 Sep; 77(9):760-4. PubMed ID: 3225770
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral absorption of poorly water-soluble drugs: computer simulation of fraction absorbed in humans from a miniscale dissolution test.
    Takano R; Sugano K; Higashida A; Hayashi Y; Machida M; Aso Y; Yamashita S
    Pharm Res; 2006 Jun; 23(6):1144-56. PubMed ID: 16715363
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human drug absorption kinetics and comparison to Caco-2 monolayer permeabilities.
    Polli JE; Ginski MJ
    Pharm Res; 1998 Jan; 15(1):47-52. PubMed ID: 9487545
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of a Clinically Relevant Dissolution Method for Metaxalone Immediate Release Formulations Based on an IVIVC Model.
    Vuletić L; Khan MZI; Špoljarić D; Radić M; Cetina-Čižmek B; Filipović-Grčić J
    Pharm Res; 2018 Jun; 35(8):163. PubMed ID: 29934663
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.